Six practice groups · two lead partners
Each practice group below carries a description of scope, a brief on representative work, and the lead partner. Engagements are staffed by the lead partner and one or two associates. The matters listed are representative; specific client names are withheld as a matter of firm policy.

01 · Practice groups in detail
Practice 01
Public and private transactions, debt and equity financings, restructurings, multi-state operator combinations, SPAC and reverse-merger structures.
Lead: Sarah Chen, Partner
Practice 02
Institutional credit facilities, post-SAFER Act bank engagements, secured-lending structures, custody arrangements, anti-money-laundering posture.
Lead: Sarah Chen, Partner
Practice 03
State licensing, multi-state regulatory harmonization, federal-policy advocacy, FDA hemp-derived-cannabinoid pathways.
Lead: Marcus Holloway, Partner
Practice 04
State and federal investigations, internal investigations, enforcement defense, voluntary disclosure programs.
Lead: Marcus Holloway, Partner
Practice 05
Trademark portfolios in cannabis-restricted classes, patent strategy for cultivation IP, brand-licensing structures, anti-counterfeiting.
Lead: Sarah Chen, Partner
Practice 06
Commercial litigation, partnership disputes, regulatory appeals, arbitration before AAA and JAMS, appellate matters.
Lead: Marcus Holloway, Partner
02 · What Precedent will decline
The firm has a defined scope. We refer the following out, with grace:
In every case where Precedent declines, we offer a referral to a firm we know can do the work well.
If your matter is in scope